SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nodality, Inc., advancing the discovery, development and use of transformative therapies across broad therapeutic categories, with a focus on immunology and oncology, announced today the presentation of research findings from its collaborative partnership with Pfizer. The collaboration is focused on systemic lupus erythematosus (SLE) product development efforts within Pfizer’s autoimmune R&D groups. The data are being featured at the American College of Rheumatology (ACR) 2014 Annual Meeting, currently taking place in Boston, Massachusetts.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
